Trials that use: Odds ratio
New to this method? Read the tutorial →
3,661 results
- A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food: primary endpoint results, effect estimate with…
- A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood: primary endpoint results, effect estimate with…
- A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood: Complete Statistical AnalysisIndependent statistical analysis of A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066: Complete Statistical AnalysisIndependent statistical analysis of A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based: Complete Statistical AnalysisIndependent statistical analysis of A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study): Complete Statistical AnalysisIndependent statistical analysis of A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study):…
- A Study in Patients With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966875).
- A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of a Single Dose of ALXN1210 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Single Dose of ALXN1210 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma: primary endpoint results, effect estimate with confidence interval,…
- A Study of Abemaciclib in Indian Women With Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Indian Women With Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body: primary endpoint results, effect estimate with confidence interval,…
- A Study of Abemaciclib in Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Abemaciclib in Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02981940).
- A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection: Complete Statistical AnalysisIndependent statistical analysis of A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG: Complete Statistical AnalysisIndependent statistical analysis of A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Ad26.COV2.S in Adults (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of A Study of Ad26.COV2.S in Adults (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04436276).
- A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency: Complete Statistical AnalysisIndependent statistical analysis of A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment: primary endpoint results, effect estimate…
- A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects: Complete Statistical AnalysisIndependent statistical analysis of A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002): Complete Statistical AnalysisIndependent statistical analysis of A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014): Complete Statistical AnalysisIndependent statistical analysis of A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart: Complete Statistical AnalysisIndependent statistical analysis of A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had…
- A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19: Complete Statistical AnalysisIndependent statistical analysis of A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1): Complete Statistical AnalysisIndependent statistical analysis of A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA): Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA): primary endpoint results, effect estimate…
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF): Complete Statistical AnalysisIndependent statistical analysis of A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF): primary endpoint results, effect estimate with confidence interval,…
- A Study of BAX 888 in Male Adults With Severe Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of A Study of BAX 888 in Male Adults With Severe Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation: Complete Statistical AnalysisIndependent statistical analysis of A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator’s Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC): Complete Statistical AnalysisIndependent statistical analysis of A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for…
- A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001): Complete Statistical AnalysisIndependent statistical analysis of A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Breastfeeding in Buprenorphine Maintained Women: Complete Statistical AnalysisIndependent statistical analysis of A Study of Breastfeeding in Buprenorphine Maintained Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01806389).
- A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074): Complete Statistical AnalysisIndependent statistical analysis of A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…